Condition: Heart Failure NYHA Class III · Heart Failure · Sponsor: Endotronix, Inc.
This retrospective, non-randomized cohort study will evaluate how well the Cordella PA Sensor System works compared to standard medication treatment in people with chronic heart failure. The study will track patients for two years to see if those using the Cordella system have fewer deaths and hospitalizations related to heart failure.
This description comes directly from the study's public registry record.
Andrea Sauerland · 630-599-7176 · andrea_sauerland@edwards.com
Max Gill · max_gill@edwards.com
Always discuss trial participation with your own doctor first.
| Endotronix | Naperville, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06783335